| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 4.652 | 36.256 | 26.385 | 5.182 | 5.536 |
| Total Income - EUR | - | - | - | - | - | 4.652 | 36.289 | 26.424 | 5.182 | 5.536 |
| Total Expenses - EUR | - | - | - | - | - | 1.456 | 10.462 | 7.222 | 2.174 | 1.767 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 3.195 | 25.827 | 19.202 | 3.008 | 3.769 |
| Net Profit/Loss - EUR | - | - | - | - | - | 3.149 | 25.464 | 18.938 | 2.527 | 3.134 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Hrndiab -Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 434 | 260 | 86 |
| Current Assets | - | - | - | - | - | 4.452 | 26.457 | 18.566 | 2.882 | 3.865 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 3.101 | 3.376 | 16.628 | 0 | 0 |
| Cash | - | - | - | - | - | 1.351 | 23.081 | 1.938 | 2.882 | 3.865 |
| Shareholders Funds | - | - | - | - | - | 3.190 | 25.551 | 18.989 | 2.656 | 3.590 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.262 | 906 | 11 | 486 | 361 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hrndiab -Med S.r.l.